Nina Levin, VP client success at Within3, discusses the importance of digital opinion leaders for field medical teams and the wider pharma sector.
In the pharma industry, engaging the right key opinion leaders (KOLs) is a key activity for any medical affairs team. Gathering insights from these experts provides the foundation to any drug development process, and this foundation allows companies to develop drugs more efficiently. However, the job of identifying experts and building enduring relationships with them can be difficult for medical affairs teams.
Medical affairs teams rely on tried and tested KOLs who are prominent in the pharmaceutical space. Pharma companies value these well-known experts to provide insights and ensure quality, but occasionally new voices are needed. For instance, an MSL may need the insight of a frontline nurse, someone working in a CRO in Asia, or even a patient who struggles with mobility issues following a specific diagnosis. Often, these individuals provide valuable insight that can potentially streamline the trial process. However, finding and engaging them can be incredibly time-consuming without the right tools.